Katalog Plus
Bibliothek der Frankfurt UAS
Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.
Dieses Ergebnis aus BASE kann Gästen nicht angezeigt werden.  Login für vollen Zugriff.

The Impact of Corticosteroid Therapy on Patients With West Nile Virus: A Retrospective Cohort Study

Title: The Impact of Corticosteroid Therapy on Patients With West Nile Virus: A Retrospective Cohort Study
Authors: Poran, Itamar; Basharim, Bar; Leibovici-Weissman, Yaara; Michaelis, Michal; Ghantous, Nassem; Eliakim-Raz, Noa
Source: The Journal of Infectious Diseases ; volume 233, issue 3, page e667-e673 ; ISSN 0022-1899 1537-6613
Publisher Information: Oxford University Press (OUP)
Publication Year: 2025
Description: Background West Nile virus (WNV) infection may result in a serious, neuroinvasive, life-threatening disease. Since there is no known therapy against the virus, treatment is based on supportive care. Little is known about the effect of corticosteroids (CS) in patients with West Nile, and their use remains controversial. This study aimed to evaluate the effect of CS treatment in patients with WNV infection. Methods A retrospective cohort study was conducted at Rabin Medical Center, including patients with WNV infection. Data were extracted from patients’ electronic medical records. Inverse probability of treatment weighting was used to adjust patient characteristics. Our exposure of interest was CS prescription during the first 48 hours. IPTW-adjusted Cox proportional hazard models were used to compare the risk of hospital mortality. Secondary outcomes included the need for mechanical ventilation or intensive care unit transfer, and the need for rehabilitation or a long-term care facility at discharge. Results Data from 150 confirmed cases were extracted. 41 (27%) patients received CSs. After adjusting for potential confounders, CS treatment was found to significantly increase hospital mortality (adjusted hazard ratio [aHR] 3.93, 95% confidence interval [CI] 1.14–13.51). A sensitivity analysis including patients with West Nile neuroinvasive disease and patients hospitalized for more than 48 hours showed consistent results. Conclusions Our study suggests that CS use in WNV patients may be associated with an increased risk of hospital mortality, highlighting the need for caution in their use and further prospective investigation.
Document Type: article in journal/newspaper
Language: English
DOI: 10.1093/infdis/jiaf601
DOI: 10.1093/infdis/jiaf601/65757022/jiaf601.pdf
Availability: https://doi.org/10.1093/infdis/jiaf601; https://academic.oup.com/jid/advance-article-pdf/doi/10.1093/infdis/jiaf601/65757022/jiaf601.pdf; https://academic.oup.com/jid/article-pdf/233/3/e667/65757022/jiaf601.pdf
Rights: https://creativecommons.org/licenses/by/4.0/
Accession Number: edsbas.652B4045
Database: BASE